Tocqueville Asset Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,404
| Closed | -$17K | – | 726 |
|
|
2022
Q1 | $17K | Buy |
+3,404
| New | +$17K | ﹤0.01% | 703 |
|
|
2021
Q4 | – | Sell |
-10,131
| Closed | -$112K | – | 776 |
|
|
2021
Q3 | $112K | Sell |
10,131
-1,100
| -10% | -$12.2K | ﹤0.01% | 714 |
|
|
2021
Q2 | $190K | Sell |
11,231
-3,509
| -24% | -$59.4K | ﹤0.01% | 716 |
|
|
2021
Q1 | $387K | Sell |
14,740
-4,280
| -23% | -$112K | 0.01% | 592 |
|
|
2020
Q4 | $688K | Buy |
19,020
+7,173
| +61% | +$259K | 0.01% | 494 |
|
|
2020
Q3 | $419K | Buy |
11,847
+3,007
| +34% | +$106K | 0.01% | 523 |
|
|
2020
Q2 | $375K | Buy |
8,840
+6,547
| +286% | +$278K | 0.01% | 535 |
|
|
2020
Q1 | $183K | Buy |
2,293
+246
| +12% | +$19.6K | ﹤0.01% | 600 |
|
|
2019
Q4 | $189K | Buy |
+2,047
| New | +$189K | ﹤0.01% | 708 |
|